EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long-term outcomes of active surveillance after DOTATATE PET/MRI–confirmed gross total resection in WHO grade 2 meningioma

Jana Ivanidze iD, Kellen Vo Vu, Umberto Tosi iD, Se Jung Chris Chang, Kate Rosen, Hannah G Otis, Peter Chernek, Alexis Watson, Arsalan Haghdel, Valentina Marulanda Corzo, Sean H Kim, David Pisapia iD und 17 weitere

Neuro-Oncology Advances · 06.01.2025 · 7 (1)

DOI: 10.1093/noajnl/vdaf210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 18.09.2025. Verfasst von Jana Ivanidze und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Weill Cornell Medicine, New York, New York. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AbstractAbstract Background Somatostatin receptor 2 (SSTR2), a highly sensitive and specific meningioma biomarker, can be imaged with [68Ga]-DOTATATE PET, improving diagnosis and treatment. The role of postoperative radiotherapy (RT) for WHO grade 2 (WHO-2) meningiomas following gross total resection (GTR) remains controversial. We hypothesized that confirmation of GTR by DOTATATE PET/MRI followed by active surveillance would yield superior progression-free survival (PFS) compared to MRI-based GTR assessment alone.

Methods

Patients with WHO-2 meningioma enrolled in a prospective registry were included if postoperative PET/MRI showed GTR and if they were managed with surveillance alone. All patients underwent serial MRI and/or PET/MRI follow-up. Kaplan–Meier analysis was used to determine PFS. A retrospective institutional comparator cohort of patients with WHO-2 meningiomas and MRI-determined GTR managed with surveillance alone was also evaluated.

Results

Twenty-eight prospective subjects (61% women, mean age 61 years) met inclusion criteria. Meningiomas were located along the convexity (50%), falx (21%), and skull base (29%). Mean mitotic count was 5.1 per 10 high-power fields; mean follow-up was 28 months (range 5-64). In the PET/MRI cohort, PFS was 90.0% at 5 years. In comparison, the MRI-only cohort (n = 33) demonstrated a 5-year PFS of 67.0% (log-rank P = .04), despite similar clinicopathologic features.

Conclusions

DOTATATE PET/MRI-confirmed GTR followed by active surveillance yielded significantly higher PFS compared to MRI-based GTR assessment in patients with WHO-2 meningioma. DOTATATE PET/MRI increases diagnostic certainty, enabling more accurate postoperative risk stratification and potentially avoiding unnecessary RT, supporting its integration into postoperative decision-making for WHO-2 meningioma.

Schlagwörter

Stichwörter der Autor:innen

DOTATATEPET/MRImeningiomaradiotherapysomatostatin receptor 2

Autor:innen und Institutionen

  • Department of Radiology, Weill Cornell Medicine, New York, New York.
  • MD Program, Weill Cornell Medicine, New York, New York.
  • Department of Neurological Surgery, Weill Cornell Medicine, New York, New York.
  • Department of Pathology, Weill Cornell Medicine, New York, New York.
  • Department of Neurology, Weill Cornell Medicine, New York, New York.
  • Department of Neurology, Columbia University, New York, New York.

ORCID-Profile: Jana Ivanidze, Umberto Tosi, David Pisapia, Rohan Ramakrishna

Zitieren

APA

Ivanidze, J., Vu, K. V., Tosi, U., Chris Chang, S. J., Rosen, K., Otis, H. G., Chernek, P., Watson, A., Haghdel, A., Corzo, V. M., Kim, S. H., Pisapia, D., Magge, R. S., Pan, P. C., Pannullo, S. C., Roytman, M., Lin, E., Nehmeh, S., Karakatsanis, N., …, & Schwartz, T. H. (2025). Long-term outcomes of active surveillance after DOTATATE PET/MRI–confirmed gross total resection in WHO grade 2 meningioma. Neuro-Oncology Advances, 7(1). https://doi.org/10.1093/noajnl/vdaf210

Vancouver

Ivanidze J, Vu KV, Tosi U, Chris Chang SJ, Rosen K, Otis HG, et al. Long-term outcomes of active surveillance after DOTATATE PET/MRI–confirmed gross total resection in WHO grade 2 meningioma. Neuro-Oncology Advances. 2025;7(1). doi:10.1093/noajnl/vdaf210

BibTeX
@article{Ivanidze2025,
  author = {Ivanidze, Jana and Vu, Kellen Vo and Tosi, Umberto and Chris Chang, Se Jung and Rosen, Kate and Otis, Hannah G and Chernek, Peter and Watson, Alexis and Haghdel, Arsalan and Corzo, Valentina Marulanda and Kim, Sean H and Pisapia, David and Magge, Rajiv S and Pan, Peter C and Pannullo, Susan C and Roytman, Michelle and Lin, Eaton and Nehmeh, Sadek and Karakatsanis, Nicolas and RoyChoudhury, Arindam and Osborne, Joseph R and Brandmaier, Andrew and Beal, Kathryn and Zonenshayn, Martin and Ramakrishna, Rohan and Stieg, Philip and Liechty, Benjamin and Knisely, Jonathan P S and Schwartz, Theodore H},
  title = {Long-term outcomes of active surveillance after DOTATATE PET/MRI–confirmed gross total resection in WHO grade 2 meningioma},
  journal = {Neuro-Oncology Advances},
  year = {2025},
  volume = {7},
  number = {1},
  doi = {10.1093/noajnl/vdaf210}
}
Kostenlos starten →